BRCA1 and ovarian neoplasm: Recent data indicate that BRCA1/2-associated HGSOCs do not show inferior outcomes when treated by NACT before the surgery, while primary surgical intervention is clearly the best approach in sporadic ovarian tumors [7, 17, 18].